US Stock MarketDetailed Quotes

XORTX Therapeutics (XRTX)

Watchlist
  • 0.5600
  • +0.0055+0.99%
Trading Jan 23 12:17 ET
3.90MMarket Cap-1.40P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

XORTX Therapeutics (XRTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-18.13%716.2K
-40.42%889.95K
-11.50%963.46K
-31.88%4.12M
-32.78%661.26K
-37.22%874.75K
-15.21%1.49M
-42.92%1.09M
-41.25%6.05M
-63.02%983.67K
Selling and administrative expenses
-28.12%392.94K
-43.05%465.83K
-6.71%477.8K
2.51%2.28M
-16.05%407.03K
7.16%546.63K
13.24%817.91K
0.33%512.15K
-7.13%2.23M
-4.86%484.85K
-General and administrative expense
-28.12%392.94K
-43.05%465.83K
-6.71%477.8K
2.51%2.28M
-16.05%407.03K
7.16%546.63K
13.24%817.91K
0.33%512.15K
-7.13%2.23M
-4.86%484.85K
Research and development costs
64.10%57.01K
175.92%186.75K
275.20%276.31K
-92.40%183.83K
-94.21%7.76K
-93.90%34.74K
-89.87%67.68K
-92.97%73.64K
-64.23%2.42M
-92.95%134.13K
Depreciation amortization depletion
13.24%29.39K
-16.40%27.63K
-19.13%25.99K
-16.05%117.27K
7.32%26.14K
57.58%25.95K
3.21%33.05K
-51.93%32.13K
140.25%139.69K
7.99%24.36K
-Depreciation and amortization
13.24%29.39K
-16.40%27.63K
-19.13%25.99K
-16.05%117.27K
7.32%26.14K
57.58%25.95K
3.21%33.05K
-51.93%32.13K
140.25%139.69K
7.99%24.36K
Other operating expenses
-11.43%236.86K
-63.53%209.74K
-61.04%183.37K
21.72%1.53M
-35.26%220.32K
-9.96%267.43K
69.40%575.05K
66.30%470.7K
17.55%1.26M
51.59%340.34K
Operating profit
18.13%-716.2K
40.42%-889.95K
11.50%-963.46K
31.88%-4.12M
32.78%-661.26K
37.22%-874.75K
15.21%-1.49M
42.92%-1.09M
41.25%-6.05M
63.02%-983.67K
Net non-operating interest income expense
-75.19%7.2K
-65.72%12.33K
-41.71%18.42K
-51.92%121.91K
-49.15%25.33K
-54.38%29.02K
-50.96%35.95K
-52.69%31.6K
144.76%253.54K
-7.26%49.82K
Non-operating interest income
-75.19%7.2K
-65.72%12.33K
-41.71%18.42K
----
----
-54.38%29.02K
-50.96%35.95K
-52.69%31.6K
----
----
Total other finance cost
----
----
----
51.92%-121.91K
----
----
----
----
-144.76%-253.54K
----
Other net income (expense)
-76.99%59.53K
-90.18%159.92K
112.56%246.36K
-81.21%683.07K
-79.12%758.47K
7,153.30%258.72K
46,688.55%1.63M
-23,298.79%-1.96M
47.25%3.63M
13,367.34%3.63M
Gain on sale of security
-76.99%59.53K
-90.18%159.92K
112.56%246.36K
-73.53%962.1K
-71.44%1.04M
7,153.30%258.72K
46,688.55%1.63M
-23,298.79%-1.96M
7.06%3.63M
281.05%3.63M
Special income (charges)
----
----
----
---279.03K
----
----
----
----
--0
----
-Less：Restructuring and merger&acquisition
----
----
----
--279.03K
----
----
----
----
--0
----
Income before tax
-10.64%-649.47K
-522.01%-717.7K
76.86%-698.67K
-53.53%-3.31M
-95.46%122.54K
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
Income tax
Net income
-10.64%-649.47K
-522.01%-717.7K
76.86%-698.67K
-53.53%-3.31M
-95.46%122.54K
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
Net income continuous Operations
-10.64%-649.47K
-522.01%-717.7K
76.86%-698.67K
-53.53%-3.31M
-95.46%122.54K
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
Minority interest income
Net income attributable to the parent company
-10.64%-649.47K
-522.01%-717.7K
76.86%-698.67K
-53.53%-3.31M
-95.46%122.54K
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-10.64%-649.47K
-522.01%-717.7K
76.86%-698.67K
-53.53%-3.31M
-95.46%122.54K
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
Basic earnings per share
35.00%-0.13
-416.67%-0.19
84.68%-0.19
-5.50%-1.15
-92.70%0.1
70.15%-0.2
107.06%0.06
-30.53%-1.24
79.12%-1.09
182.51%1.37
Diluted earnings per share
35.00%-0.13
-416.67%-0.19
84.68%-0.19
-5.50%-1.15
-92.70%0.1
70.15%-0.2
107.06%0.06
-30.53%-1.24
79.12%-1.09
182.51%1.37
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -18.13%716.2K-40.42%889.95K-11.50%963.46K-31.88%4.12M-32.78%661.26K-37.22%874.75K-15.21%1.49M-42.92%1.09M-41.25%6.05M-63.02%983.67K
Selling and administrative expenses -28.12%392.94K-43.05%465.83K-6.71%477.8K2.51%2.28M-16.05%407.03K7.16%546.63K13.24%817.91K0.33%512.15K-7.13%2.23M-4.86%484.85K
-General and administrative expense -28.12%392.94K-43.05%465.83K-6.71%477.8K2.51%2.28M-16.05%407.03K7.16%546.63K13.24%817.91K0.33%512.15K-7.13%2.23M-4.86%484.85K
Research and development costs 64.10%57.01K175.92%186.75K275.20%276.31K-92.40%183.83K-94.21%7.76K-93.90%34.74K-89.87%67.68K-92.97%73.64K-64.23%2.42M-92.95%134.13K
Depreciation amortization depletion 13.24%29.39K-16.40%27.63K-19.13%25.99K-16.05%117.27K7.32%26.14K57.58%25.95K3.21%33.05K-51.93%32.13K140.25%139.69K7.99%24.36K
-Depreciation and amortization 13.24%29.39K-16.40%27.63K-19.13%25.99K-16.05%117.27K7.32%26.14K57.58%25.95K3.21%33.05K-51.93%32.13K140.25%139.69K7.99%24.36K
Other operating expenses -11.43%236.86K-63.53%209.74K-61.04%183.37K21.72%1.53M-35.26%220.32K-9.96%267.43K69.40%575.05K66.30%470.7K17.55%1.26M51.59%340.34K
Operating profit 18.13%-716.2K40.42%-889.95K11.50%-963.46K31.88%-4.12M32.78%-661.26K37.22%-874.75K15.21%-1.49M42.92%-1.09M41.25%-6.05M63.02%-983.67K
Net non-operating interest income expense -75.19%7.2K-65.72%12.33K-41.71%18.42K-51.92%121.91K-49.15%25.33K-54.38%29.02K-50.96%35.95K-52.69%31.6K144.76%253.54K-7.26%49.82K
Non-operating interest income -75.19%7.2K-65.72%12.33K-41.71%18.42K---------54.38%29.02K-50.96%35.95K-52.69%31.6K--------
Total other finance cost ------------51.92%-121.91K-----------------144.76%-253.54K----
Other net income (expense) -76.99%59.53K-90.18%159.92K112.56%246.36K-81.21%683.07K-79.12%758.47K7,153.30%258.72K46,688.55%1.63M-23,298.79%-1.96M47.25%3.63M13,367.34%3.63M
Gain on sale of security -76.99%59.53K-90.18%159.92K112.56%246.36K-73.53%962.1K-71.44%1.04M7,153.30%258.72K46,688.55%1.63M-23,298.79%-1.96M7.06%3.63M281.05%3.63M
Special income (charges) ---------------279.03K------------------0----
-Less：Restructuring and merger&acquisition --------------279.03K------------------0----
Income before tax -10.64%-649.47K-522.01%-717.7K76.86%-698.67K-53.53%-3.31M-95.46%122.54K55.98%-587.01K110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M
Income tax
Net income -10.64%-649.47K-522.01%-717.7K76.86%-698.67K-53.53%-3.31M-95.46%122.54K55.98%-587.01K110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M
Net income continuous Operations -10.64%-649.47K-522.01%-717.7K76.86%-698.67K-53.53%-3.31M-95.46%122.54K55.98%-587.01K110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M
Minority interest income
Net income attributable to the parent company -10.64%-649.47K-522.01%-717.7K76.86%-698.67K-53.53%-3.31M-95.46%122.54K55.98%-587.01K110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -10.64%-649.47K-522.01%-717.7K76.86%-698.67K-53.53%-3.31M-95.46%122.54K55.98%-587.01K110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M
Basic earnings per share 35.00%-0.13-416.67%-0.1984.68%-0.19-5.50%-1.15-92.70%0.170.15%-0.2107.06%0.06-30.53%-1.2479.12%-1.09182.51%1.37
Diluted earnings per share 35.00%-0.13-416.67%-0.1984.68%-0.19-5.50%-1.15-92.70%0.170.15%-0.2107.06%0.06-30.53%-1.2479.12%-1.09182.51%1.37
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.10%
Sample Name
Sample Code
 +4.01%
Sample Name
Sample Code
 +2.83%
4
Amazon
AMZN
+2.34%
5
NVIDIA
NVDA
+1.58%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.21%
Sample Name
Sample Code
 +8.84%
Sample Name
Sample Code
 +5.14%
4
KE Holdings
BEKE
+4.44%
5
H World Group
HTHT
+4.05%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -